Yiwen Zhang Selected Research

galactoglucan

8/2022

Sulfated galactoglucan impedes xenografted lung cancer cell growth by blocking angiogenesis via binding BMPRs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiwen Zhang Research Topics

Disease

61	Neoplasms (Cancer) 12/2022 - 09/2009
13	Breast Neoplasms (Breast Cancer) 12/2022 - 08/2010
10	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2017
10	Infections 01/2022 - 01/2020
9	Inflammation (Inflammations) 08/2022 - 01/2017
7	Lung Neoplasms (Lung Cancer) 08/2022 - 01/2017
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2014
6	Fibrosis (Cirrhosis) 11/2022 - 10/2015
5	COVID-19 08/2022 - 10/2020
5	Melanoma (Melanoma, Malignant) 01/2022 - 08/2016
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2016
5	Multiple Myeloma 04/2017 - 01/2015
4	Wounds and Injuries (Trauma) 09/2022 - 11/2019
4	Carcinoma (Carcinomatosis) 08/2022 - 10/2017
4	Adenocarcinoma 05/2022 - 05/2020
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 09/2017
4	Non-alcoholic Fatty Liver Disease 01/2021 - 09/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2015
4	Hepatocellular Carcinoma (Hepatoma) 08/2019 - 08/2017
3	Hypertension (High Blood Pressure) 11/2022 - 07/2008
3	Hypoxia (Hypoxemia) 05/2022 - 04/2016
3	Anaplastic Thyroid Carcinoma 01/2022 - 01/2018
3	Carcinogenesis 01/2022 - 06/2015
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 10/2021 - 11/2002
3	Ischemic Stroke 10/2021 - 01/2019
3	Pathologic Processes 12/2020 - 12/2017
3	Stomach Neoplasms (Stomach Cancer) 03/2020 - 01/2019
2	Triple Negative Breast Neoplasms 12/2022 - 01/2022
2	Mental Disorders (Mental Disorder) 05/2022 - 05/2020
2	Cognitive Dysfunction 03/2022 - 05/2014
2	Pulmonary Arterial Hypertension 01/2022 - 01/2022
2	Nasopharyngeal Carcinoma 01/2022 - 08/2019
2	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2022
2	Dysbiosis 01/2022 - 01/2020
2	Necrosis 10/2021 - 10/2016
2	Anemia 10/2021 - 10/2021
2	Alzheimer Disease (Alzheimer's Disease) 07/2021 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 05/2020
2	Pain (Aches) 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2012
18	Pharmaceutical PreparationsIBA 08/2022 - 02/2011
12	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2017
7	Biological ProductsIBA 02/2022 - 06/2015
6	VaccinesIBA 01/2022 - 12/2020
5	Therapeutic UsesIBA 02/2022 - 11/2002
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2019
5	Indicators and Reagents (Reagents)IBA 10/2021 - 11/2002
4	LipidsIBA 11/2022 - 05/2017
4	AminesIBA 07/2022 - 10/2018
4	Glutathione (Reduced Glutathione)IBA 01/2022 - 09/2009
4	Peptides (Polypeptides)IBA 07/2021 - 03/2019
4	Long Noncoding RNAIBA 05/2021 - 08/2017
3	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2019
3	AntibodiesIBA 12/2022 - 10/2020
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2022 - 10/2018
3	APTIBA 05/2022 - 10/2019
3	CytokinesIBA 02/2022 - 04/2019
3	Uric Acid (Urate)IBA 01/2022 - 11/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2021
3	NanovaccinesIBA 01/2022 - 12/2020
3	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2018
3	MicellesIBA 01/2022 - 05/2019
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2019
3	AntioxidantsIBA 01/2021 - 09/2019
3	Polysaccharides (Glycans)IBA 01/2021 - 09/2019
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 11/2019
3	Caspase 3 (Caspase-3)IBA 01/2021 - 09/2017
3	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2010
2	CollagenIBA 09/2022 - 11/2002
2	EnzymesIBA 08/2022 - 09/2009
2	Gemcitabine FDA Link 05/2022 - 01/2022
2	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2022 - 07/2008
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2022
2	AntigensIBA 01/2022 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2020
2	Chimeric Antigen ReceptorsIBA 01/2022 - 11/2019
2	AlbuminsIBA 01/2022 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2021
2	Neutralizing AntibodiesIBA 01/2022 - 01/2022
2	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2019
2	Angiotensin-Converting Enzyme 2IBA 01/2022 - 12/2021
2	3' Untranslated Regions (3' UTR)IBA 12/2021 - 08/2010
2	NucleotidesIBA 12/2021 - 08/2019
2	IronIBA 10/2021 - 10/2021
2	Cadherins (E-Cadherin)IBA 10/2021 - 01/2021
2	VimentinIBA 10/2021 - 01/2021
2	Interleukin-8 (Interleukin 8)IBA 10/2021 - 04/2019
2	Tyrosine Kinase InhibitorsIBA 08/2021 - 01/2017
2	Dendrimers (Dendrons)IBA 07/2021 - 09/2020
2	AutoantibodiesIBA 01/2021 - 01/2015

Therapy/Procedure

25	Therapeutics 12/2022 - 11/2012
9	Drug Therapy (Chemotherapy) 05/2022 - 11/2012
8	Immunotherapy 01/2022 - 01/2019
7	Radiotherapy 01/2022 - 10/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2022 - 01/2014
3	Photochemotherapy (Photodynamic Therapy) 09/2020 - 10/2019
2	Oral Administration 02/2022 - 01/2021
2	Cholecystectomy 01/2022 - 01/2020